fluidigm  press releases  fluidigm appoints steve mcphail gm of production genomics fluidigm appoints steve mcphail gm of production genomics insights features spotlights applications events media archives products systems ifcs reagents custom assays software c open app catalog support access array biomark  ep c callisto cytof  helios juno polaris training services contact account accountsign out forgot password sign in register sign in to your account to access order status past orders and discussionsif you dont have an account please sign up and start one today reset password enter your email address and well email you a reset link back reset systems access array biomark hd c callisto ep helios a cytof system juno polaris insights features spotlights applications events media archives products systems ifcs reagents custom assays software c open app catalog support access array biomark  ep c callisto cytof  helios juno polaris training services contact about careers contact legal press us cn jp type to search fluidigm appoints steve mcphail gm of production genomics industry veteran to drive growth in dynamic production genomics market press release contact michaeline bunting senior director marketing fluidigm corporation    michaelinebuntingfluidigmcom south san francisco calif may   – fluidigm corporation nasdaqfldm has recruited industry veteran steven c mcphail to lead its new organization specifically focused on serving its production genomics customers production genomics remains a key strategic opportunity for fluidigm to diversify the company’s product lines and endcustomer mix “for years production genomics has been a growth driver for fluidigm and this opportunity continues to expand an organization concentrated on this market ably led by steve will help maximize our performance and contribute to the success of our production genomics customers in clinical biorepository biopharmaceutical and aggenomics markets to name a few” said gajus worthington fluidigm president and chief executive officer industry veteran to lead fluidigm’s production genomics business “we are very excited to introduce steve mcphail as the general manager of our new production genomics effort  i’ve been an admirer of steve for many years  as president and ceo of expression analysis a genomic services business he was both a customer and a trusted advisor” said worthington “under steve’s leadership expression analysis enjoyed substantial growth and success serving a wide range of production genomics customers i can’t think of anyone else better suited to lead this exciting growth opportunity for fluidigm” worthington concluded prior to joining fluidigm mcphail dedicated  years to expression analysis which was acquired by quintiles transnational corporation in  where he served as president of the postacquisition operation prior to expression analysis mcphail spent his career serving companies in the diagnostic biotechnology and medical device markets including argomed xanthon tripath imaging dynex technologies and abbott laboratories  he has significant senior management scientific and operational experience and excels in strategy development tactical execution of operational plans building outstanding management teams establishing distribution networks as well as managing mergers and acquisitions “as a fluidigm customer for several years i have had the opportunity to watch the company grow from a genomics tool provider to a diversified highgrowth life sciences company supporting genomic next generation sequencing single cell and proteomic applications  i am delighted to be joining an excellent management team in an entrepreneurial environment with significant production genomics application opportunities in a variety of large markets this is a very exciting time for fluidigm and i look forward to playing a role in the future success of the company” said mcphail fluidigm to register certain products with fda in conjunction with fluidigm’s production genomics business the company plans to register as a medical device manufacturer with the united states food and drug administration list certain of its products as class i general purpose laboratory equipment devices and expand its ce mark for sales of its products in the european union within the next  months  in addition fluidigm intends to seek fda k premarket clearance and other registrations with other regulatory agencies throughout the world on certain of its products on a selected basis and will continue to work closely with its customers to identify regulated applications as appropriate fluidigm products have been sold throughout the world to labs conducting demanding research applications although some clinical labs may decide to use fluidigm products as part of applications developed inhouse known as “laboratory developed tests” or ldts fluidigm systems are currently labeled and marketed for research use only  not for clinical diagnostic applications the clinical testing market is an important part of the company’s production genomics pursuit the announced future oversight of ldts by the fda and revised directives expected from european regulators have created increased regulatory challenges for genetic testing labs by electing to become a medical device manufacturer for applicable platform products fluidigm will provide greater value to the clinical testing market by providing labs with instruments to support their test development and deployment efforts and ease their path to comply with anticipated changes in fda and applicable european regulatory requirements  fluidigm intends to focus on addressing the need in the ldt space for general use platforms with exceptional data quality highthroughput workflows scalability and platform robustness and does not plan to produce molecular diagnostic tests  use of forwardlooking statements this press release contains forwardlooking statements within the meaning of the private securities litigation reform act of  including statements relating to fluidigm’s plans objectives expectations and strategies for its production genomics business fluidigm’s anticipated opportunities within the production genomics market and fluidigm’s plans to seek and obtain clearance or approval of certain of its products with the fda and other foreign regulatory authorities  forwardlooking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from currently anticipated results including challenges inherent in developing manufacturing launching marketing and selling new products the possible loss of key employees customers or suppliers intellectual property risks competition fluidigm’s sales marketing and distribution capabilities fluidigm’s planned sales marketing and research and development activities interruptions or delays in the supply of components or materials for or manufacturing of fluidigm products seasonal variations in customer operations unanticipated increases in costs or expenses and risks associated with international operations information on these and additional risks uncertainties and other information affecting fluidigm’s business and operating results are contained in fluidigm’s annual report on form k for the year ended december   and other filings with the securities and exchange commission additional information will also be set forth in fluidigm’s quarterly report on form q for the three months ended march   to be filed with the securities and exchange commission these forwardlooking statements speak only as of the date hereof and fluidigm disclaims any obligation to update these statements except as may be required by law about fluidigm fluidigm nasdaqfldm develops manufactures and markets life science analytical and preparatory systems for growth markets such as singlecell biology and production genomics we sell to leading academic institutions clinical laboratories and pharmaceutical biotechnology and agricultural biotechnology companies worldwide our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow increase throughput and reduce costs while providing excellent data quality fluidigm products are provided for research use only not for use in diagnostic procedures we use our website wwwfluidigmcom corporate twitter account fluidigm facebook page httpswwwfacebookcomfluidigm and linkedin page httpswwwlinkedincomcompanyfluidigmcorporation as channels of distribution of information about our products our planned financial and other announcements our attendance at upcoming investor and industry conferences and other matters  such information may be deemed material information and we may use these channels to comply with our disclosure obligations under regulation fd therefore investors should monitor our website and our social media accounts in addition to following our press releases sec filings public conference calls and webcasts for more information please visit wwwfluidigmcom fluidigm and the fluidigm logo are trademarks or registered trademarks of fluidigm corporation  contact michaeline bunting senior director marketing fluidigm corporation    michaelinebuntingfluidigmcom   mcphail steven md in boiling springs sc   chamberofcommercecom  sign up sign in contact us   search   near   home » south carolina » boiling springs » optometrists » mcphail steven md mcphail steven md  reviews  stars  based on  reviews  highway  boiling springs south carolina        print  save  directions about mcphail steven md is located at the address  highway  in boiling springs south carolina  they can be contacted via phone at   for pricing hours and directions mcphail steven md specializes in foot disorders back pain cysts mcphail steven md provides dermabrasion liposuction aesthetic procedures to its customers for maps and directions to mcphail steven md view the map to the right for reviews of mcphail steven md see below business features products sunglasses  daily wear contacts  designer eyewear  supplements  plastic lenses  transition lenses  childrens eyewear  antiaging products  uvprotected lenses  orthotics services private care  xrays  aesthetic procedures  skin surgery  dermabrasion  rehabilitation  skin care  birth delivery  pap smears  liposuction specialties back pain  callouses  infections  headaches  moles  cysts  foot disorders  orthotics  spinal conditions  nearsightedness   information contact information phone   additional information credit cards visa master card american express professionals on staff optometrists surgeons professionals on staff syn od categories optometrists general practice health care physicians reviews add you must sign in to post reviews by on click here to be the first to review this business  reviews     site map faq privacy policy terms of use about partners chamber partner program chamber member benefits top cities atlanta bronx brooklyn chicago cleveland dallas denver detroit houston las vegas los angeles miami minneapolis new york philadelphia phoenix saint louis san antonio san diego san jose   chamberofcommercecom steven c mcphail executive profile  biography  bloomberg july    pm et life sciences tools and services company overview of fluidigm corporation snapshotpeople  overviewboard memberscommittees executive profile steven c mcphail chief commercial officer fluidigm corporationagetotal calculated compensationthis person is connected to  board members in  different organizations across  different industriessee board relationshipsas of fiscal year  background mr steven c mcphail also known as steve has been the chief commercial officer at fluidigm corporation since august  mr mcphail served as general manager of production genomics at fluidigm corporation since may  until july  mr mcphail served as the chief executive officer of expression analysis inc since february  and also served as its president he dedicated  years to expression analysis prior to joining expression analysis he served as  the executive vice president and chief operating officer of argomed inc he developed and implemented all company and product branding strategies from  to  he increased total argomed inc revenue by more than  percent in addition he completed the sale of argomed to acmi corp in december  before his association with argomed he held seniorlevel sales marketing and business development positions for xanthon tripath imaging dynex technologies and abbott laboratories he also has extensive experience in executing mergers and acquisitions developing and implementing strategic marketing plans and in establishing global customer and distribution networks he serves as a director of expression analysis inc he serves as director of improve care now he serves on the board of the nc childrens hospital and the pediatric inflammatory bowel disease network mr mcphail holds a bs in biology from san diego state universityread full background corporate headquarters  shoreline courtsouth san francisco california united statesphone fax  board members memberships directorexpression analysis incdirectorimprove care now inc education bs san diego state university other affiliations argomed incsan diego state universityexpression analysis incimprove care now inc annual compensation salarytotal annual compensation stocks options restricted stock awardsall other compensationexercisable optionsexercisable options valueunexercisable optionsunexercisable options valuetotal value of optionstotal number of options total compensation total annual cash compensationtotal short term compensationother long term compensationtotal calculated compensation request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup competitor compensationnamepositioncompanycompensationdouglas m vanoort chairman of the board  ceoneogenomics incktimothy b johnson president ceo  directorhtg molecular diagnostics inckr bradley gray president ceo  directornanostring technologies inckmichael w hunkapiller phdexecutive chairman chief executive officer and presidentpacific biosciences of california incmatthew rabinowitz phdcofounder chairman chief executive officer and presidentnatera inckcompensation as of fiscal year  sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact fluidigm corporation please visit  company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close fluidigm appoints steve mcphail general manager of production genomics business  thestreet action alerts plus access aapjim cramers best stocks for charitable trust portfoliomost recent trade alert investing rules trading commandments real money access rm rules of investingjim cramers best stocks for  commandmentsstressed out stockscramers blog cramer mad money etfs futures markets much more banksbiotechretailtechpersonal financeretirementfinancial advisor centerhow to spendoptionsfixed incomevideo privacy policyterms of use  thestreet inc all rights reserved djia nasdaq sp  market data updated sign in your memberships your account account preferences alerts newsletters subscribe logout subscribe access insights and guidance from our wall street pros find the product thats right for you action alerts plus action alerts options daily swing trade income seeker quant ratings real money real money pro stocks under  top stocks trifecta stocks real money pro portfolio chairmans club compare all chatter on the street fluidigm appoints steve mcphail general manager of production genomics business business wire may    pm edt fluidigm corporation nasdaqfldm has recruited industry veteran steven c mcphail to lead its new organization specifically focused on serving its production genomics customers production genomics remains a key strategic opportunity for fluidigm to diversify the companys product lines and endcustomer mix for years production genomics has been a growth driver for fluidigm and this opportunity continues to expand an organization concentrated on this market ably led by steve will help maximize our performance and contribute to the success of our production genomics customers in clinical biorepository biopharmaceutical and aggenomics markets to name a few said gajus worthington fluidigm president and chief executive officer industry veteran to lead fluidigms production genomics business we are very excited to introduce steve mcphail as the general manager of our new production genomics effort ive been an admirer of steve for many years as president and ceo of expression analysis a genomic services business he was both a customer and a trusted advisor said worthington under steves leadership expression analysis enjoyed substantial growth and success serving a wide range of production genomics customers i cant think of anyone else better suited to lead this exciting growth opportunity for fluidigm worthington concluded prior to joining fluidigm mcphail dedicated  years to expression analysis which was acquired by quintiles transnational corporation in  where he served as president of the postacquisition operation prior to expression analysis mcphail spent his career serving companies in the diagnostic biotechnology and medical device markets including argomed xanthon tripath imaging dynex technologies and abbott laboratories he has significant senior management scientific and operational experience and excels in strategy development tactical execution of operational plans building outstanding management teams establishing distribution networks as well as managing mergers and acquisitions as a fluidigm customer for several years i have had the opportunity to watch the company grow from a genomics tool provider to a diversified highgrowth life sciences company supporting genomic next generation sequencing single cell and proteomic applications i am delighted to be joining an excellent management team in an entrepreneurial environment with significant production genomics application opportunities in a variety of large markets this is a very exciting time for fluidigm and i look forward to playing a role in the future success of the company said mcphail if you liked this article you might like  stocks under  poised for big breakouts these under stocks are within range of triggering breakout trades heres how to play them roberto pedone dec    am est medtronic patterson among days biggest losers trump continues to pressure healthcare sector presidentelect trumps vague healthcare policy has put the  trillion industry on edge vicky huang nov    pm est  stocks insiders love right now insiders at these companies including hertz are scooping up shares of their own stock lately roberto pedone nov    pm est trade these  stocks under  for huge profits when a stock makes a largepercentage move it is often just the start of a new major trend  a trend that can lead to huge profits roberto pedone jul    am edt trending facebook could plunge by  or more in a few hours ford let us drive its tough new pickup truck and we couldnt believe the rip your face off power fords mustang is americas most popular classic car corning takes damaging hit on earnings  heres where investors can buy advanced micro devices could explode another  within hours chart advertising partners  thestreet inc all rights reservedaction alerts plus is a registered trademark of thestreet inc compare brokers steven w mcphail  kent wa  company information products resources my account talk to a db advisor  business directory wa kent offices and clinics of dentists offices and clinics of dentists steven w mcphail s steven w mcphail claim this business  se nd pl apt a kent wa  get directions   business info founded  incorporated annual revenue  employee count  industries offices and clinics of dentists contacts steven w mcphail contact business your email address subject message send message company summary steven w mcphail was founded in  steven w mcphail specializes in offices and clinics of dentists verified status unverified address unverified last verified  phone unverified payment method unverified view full report similar businesses nearby our similar businesses nearby shows similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile competitive landscape our competitive landscape shows how this business compares to similar businesses in their industry and region based on information found in their dun  bradstreet credibility review profile payments accepted no data hours sunday   monday   tuesday   wednesday   thursday   friday   saturday   s view additional data select from over  networks below to view available data about this business if this data is unavailable or inaccurate and you own or represent this business click here for more information on how you may be able to correct it credibility review google facebookcom yellowbookcom bingcom yellowpagescom merchantcircle tele atlas tomtom twittercom aol mapquest yahoo local applesiri groupon hotfrogcom comcastnet search reachlocal admedia dealsplus shoptopiacom alteryx dogtime media kslcom sirtune americantownscom driverside kudzucom specialsagentcom answerscom egood lawinfocom spotlikescom anywhocom egumball likenesscom spotzot eservicelog mapmyrun technocom apartmentguidecom ezlocalcom eztousecom teleroute aroundmecom metropolistcom therapistscom atlanta newhomes findlawcom time out new york avantar findthebestcom mojopagescom bb yellowpages fivestar software mycitywaycom tripadvisor bckyrdcom giftcardscom mycouponscom beachcaliforniacom golocalcom mymovecom upmesocialcom belo goodinfo newsgazette nokia usdirectorycom carscom nomao centzycom hibu openlistcom chacha search homeplatecom ownlocalcom visikard challamacom homestore patchcom voltari citybot pelopidas vouchd classifiedads hostway placeiq walkscorecom cloudmade hoodoyou planetdiscovercom weddingwirecom powerprofiles where inc contractorscom igolocalcom radiate media wikiocity couponmap indeedcom wimgocom crowdspot innova electronics intellistrand realtorcom datasphere inthemocom replycom yellowbotcom jiwire rocket fuel yellowpagecitycom dmvorg justclicklocalcom dirxion keencom zidstercom photos business credit report receive a onetime comprehensive credit report on this company get full credit report facebook twitter yelp call  to speak with a db advisor today customer resources products education center business articles  insights glossary contact us customer support communication preferences search for db duns our company about us company history business credit history careers press releases news success stories hoovers our network partners affiliates blog access to capital entrepreneurial initiative db international supplieredge site links business directory site map pipeda privacy policy website terms of service product license agreement  dun  bradstreet inc  all rights reserved steven mcphail   facebook facebook？english us한국어français francebahasa indonesiapolskiespañolportuguês brasildeutschitalianomessengerfacebook liteinstagramcookie facebook   steven c steve mcphail fluidigm corporation nasdaq fldm msc massspeccapitalcom  the mass spectrometry web portal personmcphailstevenstevefluidigmcorporationnasdaqfldmgrouphtml zum inhalt home about us contact news people products deals organisations » follow us on twitter » get free newsletter top news sartorius lothar kappich new supervisory board chairman hans e bishop to join agilent�s board of directors siscapa licenses lcms assay technology to waters numares metabolomic network for bladder cancer diagnostics genedata selector expands partnership with ab enzymes » more news » submit your news   upcoming events ismar  qu�bec city aacc annual meeting  clinical lab expo  san diego aacc  san diego wedbush pacgrow healthcare conference  new york bmss  manchester afm biomed conference  krak�w citi�s th annual biotech conference  boston baird global healthcare conference  new york jasis  chiba esmo  congress madrid goldman sachs annual biotech symposium  london msacl  eu salzburg morgan stanley global healthcare conference  new york jp morgan london smallmid cap conference  boaml global healthcare conference  london hupo  dublin th annual world congress » more events » submit your event   associations dgms deutsche gesellschaft f�r massenspektrometrie imsf international mass spectrometry foundation asms american society for mass spectrometry tiaft the international association of forensic toxicologists casss � an international separation science society international federation of clinical chemistry and laboratory medicine ifcc facss the federation of analytical chemistry and spectroscopy societies » more associations » submit your association   partners » media partners » become a partner   advertisement person › detailssteven c steve mcphail fluidigm corporation nasdaq fldmmcphail steven c steve fluidigm � general manager production genomics before quinitles  expression analysis  organisation fluidigm corporation nasdaq fldm   group fluidigm group   formermajor organisation expression analysis inc ea   group quintiles ims group product genomic services       fluidigm corporation  press release fluidigm appoints steve mcphail gm of production genomics industry veteran to drive growth in dynamic production genomics market south san francisco ca fluidigm corporation nasdaqfldm has recruited industry veteran steven c mcphail to lead its new organization specifically focused on serving its production genomics customers production genomics remains a key strategic opportunity for fluidigm to diversify the company�s product lines and endcustomer mix �for years production genomics has been a growth driver for fluidigm and this opportunity continues to expand an organization concentrated on this market ably led by steve will help maximize our performance and contribute to the success of our production genomics customers in clinical biorepository biopharmaceutical and aggenomics markets to name a few� said gajus worthington fluidigm president and chief executive officer industry veteran to lead fluidigm�s production genomics business �we are very excited to introduce steve mcphail as the general manager of our new production genomics effort i�ve been an admirer of steve for many years as president and ceo of expression analysis a genomic services business he was both a customer and a trusted advisor� said worthington �under steve�s leadership expression analysis enjoyed substantial growth and success serving a wide range of production genomics customers i can�t think of anyone else better suited to lead this exciting growth opportunity for fluidigm� worthington concluded prior to joining fluidigm mcphail dedicated  years to expression analysis which was acquired by quintiles transnational corporation in  where he served as president of the postacquisition operation prior to expression analysis mcphail spent his career serving companies in the diagnostic biotechnology and medical device markets including argomed xanthon tripath imaging dynex technologies and abbott laboratories he has significant senior management scientific and operational experience and excels in strategy development tactical execution of operational plans building outstanding management teams establishing distribution networks as well as managing mergers and acquisitions �as a fluidigm customer for several years i have had the opportunity to watch the company grow from a genomics tool provider to a diversified highgrowth life sciences company supporting genomic next generation sequencing single cell and proteomic applications i am delighted to be joining an excellent management team in an entrepreneurial environment with significant production genomics application opportunities in a variety of large markets this is a very exciting time for fluidigm and i look forward to playing a role in the future success of the company� said mcphail fluidigm to register certain products with fda in conjunction with fluidigm�s production genomics business the company plans to register as a medical device manufacturer with the united states food and drug administration list certain of its products as class i general purpose laboratory equipment devices and expand its ce mark for sales of its products in the european union within the next  months in addition fluidigm intends to seek fda k premarket clearance and other registrations with other regulatory agencies throughout the world on certain of its products on a selected basis and will continue to work closely with its customers to identify regulated applications as appropriate fluidigm products have been sold throughout the world to labs conducting demanding research applications although some clinical labs may decide to use fluidigm products as part of applications developed inhouse known as �laboratory developed tests� or ldts fluidigm systems are currently labeled and marketed for research use only  not for clinical diagnostic applications the clinical testing market is an important part of the company�s production genomics pursuit the announced future oversight of ldts by the fda and revised directives expected from european regulators have created increased regulatory challenges for genetic testing labs by electing to become a medical device manufacturer for applicable platform products fluidigm will provide greater value to the clinical testing market by providing labs with instruments to support their test development and deployment efforts and ease their path to comply with anticipated changes in fda and applicable european regulatory requirements fluidigm intends to focus on addressing the need in the ldt space for general use platforms with exceptional data quality highthroughput workflows scalability and platform robustness and does not plan to produce molecular diagnostic tests use of forwardlooking statements this press release contains forwardlooking statements within the meaning of the private securities litigation reform act of  including statements relating to fluidigm�s plans objectives expectations and strategies for its production genomics business fluidigm�s anticipated opportunities within the production genomics market and fluidigm�s plans to seek and obtain clearance or approval of certain of its products with the fda and other foreign regulatory authorities forwardlooking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from currently anticipated results including challenges inherent in developing manufacturing launching marketing and selling new products the possible loss of key employees customers or suppliers intellectual property risks competition fluidigm�s sales marketing and distribution capabilities fluidigm�s planned sales marketing and research and development activities interruptions or delays in the supply of components or materials for or manufacturing of fluidigm products seasonal variations in customer operations unanticipated increases in costs or expenses and risks associated with international operations information on these and additional risks uncertainties and other information affecting fluidigm�s business and operating results are contained in fluidigm�s annual report on form k for the year ended december   and other filings with the securities and exchange commission additional information will also be set forth in fluidigm�s quarterly report on form q for the three months ended march   to be filed with the securities and exchange commission these forwardlooking statements speak only as of the date hereof and fluidigm disclaims any obligation to update these statements except as may be required by law about fluidigm fluidigm nasdaqfldm develops manufactures and markets life science analytical and preparatory systems for growth markets such as singlecell biology and production genomics we sell to leading academic institutions clinical laboratories and pharmaceutical biotechnology and agricultural biotechnology companies worldwide our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow increase throughput and reduce costs while providing excellent data quality fluidigm products are provided for research use only not for use in diagnostic procedures we use our website wwwfluidigmcom corporate twitter account fluidigm facebook page httpswwwfacebookcomfluidigm and linkedin page httpswwwlinkedincomcompanyfluidigmcorporation as channels of distribution of information about our products our planned financial and other announcements our attendance at upcoming investor and industry conferences and other matters such information may be deemed material information and we may use these channels to comply with our disclosure obligations under regulation fd therefore investors should monitor our website and our social media accounts in addition to following our press releases sec filings public conference calls and webcasts for more information please visit wwwfluidigmcom fluidigm and the fluidigm logo are trademarks or registered trademarks of fluidigm corporation  contact howard high fellow corporate communication and press relations fluidigm corporation  office  mobile howardhighfluidigmcom     record changed  advertisement more documents for steven c steve mcphail  fluidigm corporation  press release fluidigm and opgen enter into strategic agreement developing multidrug resistance testing kits and equipment south san francisco ca  gaithersburg md  fluidigm corporation  press release fluidigm brings automated targeted library prep to juno south san francisco ca  fluidigm corporation  press release fluidigm appoints steve mcphail gm of production genomics industry veteran to drive growth in dynamic production genomics market south san francisco ca to subscribe to our free monthly mass spectrometry newsletter please send an email to infoiitode and simply fill the subject line with the word �msc newsletter� to get even more information please take a look at our gs professional services offering and read the genesensor product flyer pdf file please visit also our web portals for the eurpean life sciences and the life sciences in germanspeaking europe de at  ch at lifesciencesgermanycom and lifescienceseuropecom advertisement » top advertisements � imprint    � contact    the use of this website requires to accept the disclaimer     a project of iito business intelligence   made in germany mcphail steven md in boiling springs south carolina with reviews  ypcomstart your search by typing in the business name below what do you want to find wheremy current locationsearchhomeboiling springs scmcphail steven mdboiling springs sc mcphail steven mdabout search resultsabout search resultsyp  the real yellow pagessm  helps you find the right local businesses to meet your specific needs search results are sorted by a combination of factors to give you a set of choices in response to your search criteria these factors are similar to those you might use to determine which business to select from a local yellow pages directory including proximity to where you are searching expertise in the specific services or products you need and comprehensive business information to help evaluate a businesss suitability for you “preferred” listings or those with featured website buttons indicate yp advertisers who directly provide information about their businesses to help consumers make more informed buying decisions yp advertisers receive higher placement in the default ordering of search results and may appear in sponsored listings on the top side or bottom of the search results pagesortdefaultdefaultdistanceratingname a  zsponsored linksadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection leyland steven md e wood stspartanburg sc  physicians  surgeonsadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection stephen cherry md skylyn dr ste spartanburg sc  physicians  surgeonsfrom business stephen cherry md offers comprehensive cardiology services in the greater spartanburg areaadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection harley r stephen md boiling springs rdspartanburg sc  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection phillips stephen a md e wood stspartanburg sc  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection garrell stephen l md n pine stspartanburg sc  physicians  surgeons nephrologyadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection hess steven p md powell mill rdspartanburg sc  physicians  surgeonswebsiteservicesadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection bailes steven md powell mill rdspartanburg sc  physicians  surgeonswebsiteservicesadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection yost stephen a md reidville rdspartanburg sc  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection stephen j bogan md facs w floyd baker blvdgaffney sc  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection yarborough c stephen md memorial drive extgreer sc  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection brackbill stephen p md memorial drive extgreer sc  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection corso steven md  palmetto hematology oncology tiffany park  agaffney sc  physicians  surgeons oncologyadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection steven b singleton md s highway  ste greer sc  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection jones stephen m md batesville rdsimpsonville sc  physicians  surgeons pediatricswebsitegreat service really like the practiceadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection garrell stephen l md e buford stgaffney sc  physicians  surgeonsadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection steven md lewis facog n limestone st ste bgaffney sc  physicians  surgeonsadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection hamberis steve j md s highway greenville sc  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection gore stephen t md s ridgecrest averutherfordton nc  physicians  surgeonsadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection stephen lookadoo jr md s highway greenville sc  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection saunders steve p md english oak rdsimpsonville sc  physicians  surgeonsadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection stephen s scott md oak stforest city nc  physicians  surgeonsskin carewebsiteservicesadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection lysak steven z md creekside park ctgreenville sc  physicians  surgeons anesthesiologyadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection pusker steven h md creekside park ctgreenville sc  physicians  surgeonsadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection ridgeway stephen r md international drgreenville sc  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection steven j getz md  getz steven j md commonwealth drgreenville sc  physicians  surgeonsadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection price stephen w md patewood drgreenville sc  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection graddick steven l md verdae blvdgreenville sc  physicians  surgeonswebsiteservicesadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection stevens christopher e md northpark drcolumbus in  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection stephen dyar md innovation drgreenville sc  physicians  surgeonswebsiteadd to mybookremove from mybookadded to your health collectionerror when adding to health collectionthis business was removed from the health collection johnson steven d md innovation dr ste greenville sc  physicians  surgeonswebsiteservicessponsored linksshowing of resultsnextmap viewsponsoredspartanburg dermatology and skin surgery clinic pc n church street pl spartanburg sc  serving upstate south carolina since websitedirectionsmore infocenter for neurology e blackstock rd spartanburg sc  directionsmore infofoothills nephrology dillon dr spartanburg sc  websiteyp addirectionsmore infolittlefield ronald h md n pine st spartanburg sc  contact us for informationwebsitedirectionsmore infocarolina foot care llc john b white sr blvd spartanburg sc  websitedirectionsmore infopediatric evening clinic e saint john st spartanburg sc  contact us for informationwebsitedirectionsmore infotarazi sylvia md serpentine dr spartanburg sc  directionsmore infospartanburg nephrology n pine st spartanburg sc  websitedirectionsmore infobariatric clinic e blackstock rd spartanburg sc  weight losswebsiteget a discountdirectionsmore infocarolina hand center pa the serpentine dr spartanburg sc  websitevirtual tourdirectionsmore infoadvanced eye care of the upstate pa enterprise blvd greenville sc  websitesee our servicesvirtual tourdirectionsmore infoanderson ent  facial plastics cornelia rd anderson sc  websitedirectionsmore inforogers dermatology pa cleveland ct unit b greenville sc  diseases of the skin hair  nailswebsitedirectionsmore infopiedmont physical medicine saint francis dr greenville sc  not like other pain doctorswebsitedirectionsmore inforogers robert m md mills ave greenville sc  diseases and surgery of skin hair and nailswebsitedirectionsvideomore infowilson robert a md e north st greenville sc  directionsmore infodermatology associates pa medical ridge dr greenville sc  other location   tanner rd  websitedirectionsmore infolaser spine instituteserving the boiling springs area websitelocal listingsvideomore infodidnt find what you were looking formagnifying glass we just redesigned ypcom do you like it× likenot a fan× thank youfeedback fluidigm appoints steve mcphail general manager of production genomics business menu menu home optical networking virtualization hyperscale data centers enews contact us rss feeds transforming network infrastructure industry news may   fluidigm appoints steve mcphail general manager of production genomics business fluidigm corporation nasdaqfldm has recruited industry veteran steven c mcphail to lead its new organization specifically focused on serving its production genomics customers production genomics remains a key strategic opportunity for fluidigm to diversify the companys product lines and endcustomer mix for years production genomics has been a growth driver for fluidigm and this opportunity continues to expand an organization concentrated on this market ably led by steve will help maximize our performance and contribute to the success of our production genomics customers in clinical biorepository biopharmaceutical and aggenomics markets to name a few said gajus worthington fluidigm president and chief executive officer industry veteran to lead fluidigms production genomics business we are very excited to introduce steve mcphail as the general manager of our new production genomics effort ive been an admirer of steve for many years as president and ceo of expression analysis a genomic services business he was both a customer and a trusted advisor said worthington under steves leadership expression analysis enjoyed substantial growth and success serving a wide range of production genomics customers i cant think of anyone else better suited to lead this exciting growth opportunity for fluidigm worthington concluded prior to joining fluidigm mcphail dedicated  years to expression analysis which was acquired by quintiles transnational corporation in  where he served as president of the postacquisition operation prior to expression analysis mcphail spent his career serving companies in the diagnostic biotechnology and medical device markets including argomed xanthon tripath imaging dynex technologies and abbott laboratories he has significant senior management scientific and operational experience and excels in strategy development tactical execution of operational plans building outstanding management teams establishing distribution networks as well as managing mergers and acquisitions as a fluidigm customer for several years i have had the opportunity to watch the company grow from a genomics tool provider to a diversified highgrowth life sciences company supporting genomic next generation sequencing single cell and proteomic applications i am delighted to be joining an excellent management team in an entrepreneurial environment with significant production genomics application opportunities in a variety of large markets this is a very exciting time for fluidigm and i look forward to playing a role in the future success of the company said mcphail fluidigm to register certain products with fda in conjunction with fluidigms production genomics business the company plans to register as a medical device manufacturer with the united states food and drug administration list certain of its products as class i general purpose laboratory equipment devices and expand its ce mark for sales of its products in the european union within the next  months in addition fluidigm intends to sek fda k premarket clearance and other registrations with other regulatory agencies throughout the world on certain of its products on a selected basis and will continue to work closely with its customers to identify regulated applications as appropriate fluidigm products have been sold throughout the world to labs conducting demanding research applications although some clinical labs may decide to use fluidigm products as part of applications developed inhouse known as laboratory developed tests or ldts fluidigm systems are currently labeled and marketed for research use only  not for clinical diagnostic applications the clinical testing market is an important part of the companys production genomics pursuit the announced future oversight of ldts by the fda and revised directives expected from european regulators have created increased regulatory challenges for genetic testing labs by electing to become a medical device manufacturer for applicable platform products fluidigm will provide greater value to the clinical testing market by providing labs with instruments to support their test development and deployment efforts and ease their path to comply with anticipated changes in fda and applicable european regulatory requirements fluidigm intends to focus on addressing the need in the ldt space for general use platforms with exceptional data quality highthroughput workflows scalability and platform robustness and does not plan to produce molecular diagnostic tests use of forwardlooking statements this press release contains forwardlooking statements within the meaning of the private securities litigation reform act of  including statements relating to fluidigms plans objectives expectations and strategies for its production genomics business fluidigms anticipated opportunities within the production genomics market and fluidigms plans to seek and obtain clearance or approval of certain of its products with the fda and other foreign regulatory authorities forwardlooking statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from currently anticipated results including challenges inherent in developing manufacturing launching marketing and selling new products the possible loss of key employees customers or suppliers intellectual property risks competition fluidigms sales marketing and distribution capabilities fluidigms planned sales marketing and research and development activities interruptions or delays in the supply of components or materials for or manufacturing of fluidigm products seasonal variations in customer operations unanticipated increases in costs or expenses and risks associated with international operations information on these and additional risks uncertainties and other information affecting fluidigms business and operating results are contained in fluidigms annual report on form k for the year ended december   and other filings with the securities and exchange commission additional information will also be set forth in fluidigms quarterly report on form q for the three months ended march   to be filed with the securities and exchange commission these forwardlooking statements speak only as of the date hereof and fluidigm disclaims any obligation to update these statements except as may be required by law about fluidigm fluidigm nasdaqfldm develops manufactures and markets life science analytical and preparatory systems for growth markets such as singlecell biology and production genomics we sell to leading academic institutions clinical laboratories and pharmaceutical biotechnology and agricultural biotechnology companies worldwide our systems are based on proprietary microfluidics and multiparameter mass cytometry technology and are designed to significantly simplify experimental workflow increase throughput and reduce costs while providing excellent data quality fluidigm products are provided for research use only not for use in diagnostic procedures we use our website wwwfluidigmcom corporate twitter news  alert account fluidigm facebook page httpswwwfacebookcomfluidigm and linkedin news  alert page httpswwwlinkedincomcompanyfluidigmcorporation as channels of distribution of information about our products our planned financial and other announcements our attendance at upcoming investor and industry conferences and other matters such information may be deemed material information and we may use these channels to comply with our disclosure obligations under regulation fd therefore investors should monitor our website and our social media accounts in addition to following our press releases sec news  alert filings public conference calls and webcasts for more information please visit wwwfluidigmcom fluidigm and the fluidigm logo are trademarks or registered trademarks of fluidigm corporation  back to transforming network infrastructures homepage  home click here to share your opinion  has your company evaluated how to integrate ai artificial intelligence into your operations workstreams featured blog entries day  at interop itx  the final day we had an eventful week exhibiting at interop itx after lots of great conversations a wellattended presentation by our ceo mh raza about automating the physical layer and a wealth of different answers to our survey questions its time to travel home to connecticut first though heres a roundup of day  day  at interop itx  top of the stretch the middle and longest day was filled with fiber mountain sponsored an interop itx theater presentation on wednesday  delivered by mh raza fiber mountain ceo entitled automating the physical layer the audience was standing room only and several attendees came to our booth immediately after the presentation and learned more about the glass core and were off at interop itx  we are back in las vegas this time at interop itx  the rejuvenated version of interop as i have written in the past interop has a long history back to the mids and has reinvented itself many times interop itx  is the newest edition with only paid attendees and no more free passes to the expo floor ubm the owner of interop intends to increase the quality of attendees sessions and leads for exhibitors and sponsors industry news   inpixon announces technology refresh deal with leading beverage distributor    stratoscale hybrid cloud survey reveals  out of  enterprises fear vendor lockin and avoid running sensitive data in the public cloud    global hypervisor market to grow  during  ease of operating  managing the virtual infrastructure    solarflare opens market for  million firewalls per year with worlds first nicbased hardware server firewall